KY

Kavya Yagalla

Active Director Designated Partner DIN 11439786
DIN 11439786 First appointment Dec 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kavya Yagalla

Data last updated:

Kavya Yagalla is a Designated Partner at Genesis Drugs And Pharmaceuticals Llp (since 2025). The company operates in Pharma.

DIN 11439786
Primary Designation Designated Partner
Industry Pharma
First Appointment 19 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 Dec 20252025Active

Board colleagues of Kavya Yagalla

NameDINCompanyDesignation
Shaik Afroz11439787Genesis Drugs And Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Genesis Drugs And Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Kavya Yagalla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kavya Yagalla

Kavya Yagalla currently holds 1 directorship: Genesis Drugs And Pharmaceuticals Llp (Designated Partner, since 19 Dec 2025).

Kavya Yagalla was first appointed on 19 Dec 2025 as Designated Partner at Genesis Drugs And Pharmaceuticals Llp.

The current boards of Kavya Yagalla's companies include Shaik Afroz (Genesis Drugs And Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available